News blog

Europe improves oversight of medicines

The European Union (EU) has tightened oversight rules for drugs, in response to the scandal over anti-diabetic medicine Mediator that erupted in France two years ago (press release). 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE